Search research articles
Contact Us
Filters
Showing results (451-460 of 488) with videos related to
Page
of 49
Sort By:
Journal of Virology
|
February 13, 2015
Deficiency of the B cell-activating factor receptor results in limited CD169+ macrophage function during viral infection
Haifeng C Xu, Jun Huang, Vishal Khairnar, et al.
NEJM Evidence
|
April 28, 2026
Clonal Dynamics of Hematopoiesis in Aplastic Anemia after Immunosuppression and Eltrombopag
Deniz Ece Kaya, Riley Cook, Simona Iacobelli, et al.
Journal of Clinical Immunology
|
August 22, 2017
Detection of Sp110 by Flow Cytometry and Application to Screening Patients for Veno-occlusive Disease with Immunodeficiency
Florian A Marquardsen, Fabian Baldin, Florian Wunderer, et al.
Blood Advances
|
October 25, 2024
Long-term real-world evidence of CPX-351 of high-risk patients with AML identified high rate of negative MRD and prolonged OS
Thomas Cluzeau, Fabio Guolo, Edmond Chiche, et al.
British Journal of Haematology
|
April 19, 2022
A randomised phase II study of azacitidine (AZA) alone or with Lenalidomide (LEN), Valproic acid (VPA) or Idarubicin (IDA) in higher-Risk MDS or low blast AML: GFM's "pick a winner" trial, with the impact of somatic mutations
Lionel Adès, Nicolas Duployez, Agnes Guerci-Bresler, et al.
Blood
|
April 20, 2022
Prognostic impact of DDX41 germline mutations in intensively treated acute myeloid leukemia patients: an ALFA-FILO study
Nicolas Duployez, Laëtitia Largeaud, Matthieu Duchmann, et al.
American Journal of Hematology
|
December 31, 2013
Azacitidine in untreated acute myeloid leukemia: a report on 149 patients
Sylvain Thépot, Raphael Itzykson, Valerie Seegers, et al.
Nature Communications
|
February 19, 2015
CEACAM1 induces B-cell survival and is essential for protective antiviral antibody production
Vishal Khairnar, Vikas Duhan, Sathish Kumar Maney, et al.
Nature Immunology
|
March 25, 2022
Author Correction: DOCK8 functions as an adaptor that links TLR-MyD88 signaling to B cell activation
Haifa H Jabara, Douglas R McDonald, Erin Janssen, et al.
Nature Immunology
|
May 15, 2012
DOCK8 functions as an adaptor that links TLR-MyD88 signaling to B cell activation
Haifa H Jabara, Douglas R McDonald, Erin Janssen, et al.
Page
of 49
Search research articles
Search
Showing results (451-460 of 488) with videos related to
Sort By:
Page
of 49
Journal of Virology
|
February 13, 2015
Deficiency of the B cell-activating factor receptor results in limited CD169+ macrophage function during viral infection
Haifeng C Xu, Jun Huang, Vishal Khairnar, et al.
NEJM Evidence
|
April 28, 2026
Clonal Dynamics of Hematopoiesis in Aplastic Anemia after Immunosuppression and Eltrombopag
Deniz Ece Kaya, Riley Cook, Simona Iacobelli, et al.
Journal of Clinical Immunology
|
August 22, 2017
Detection of Sp110 by Flow Cytometry and Application to Screening Patients for Veno-occlusive Disease with Immunodeficiency
Florian A Marquardsen, Fabian Baldin, Florian Wunderer, et al.
Blood Advances
|
October 25, 2024
Long-term real-world evidence of CPX-351 of high-risk patients with AML identified high rate of negative MRD and prolonged OS
Thomas Cluzeau, Fabio Guolo, Edmond Chiche, et al.
British Journal of Haematology
|
April 19, 2022
A randomised phase II study of azacitidine (AZA) alone or with Lenalidomide (LEN), Valproic acid (VPA) or Idarubicin (IDA) in higher-Risk MDS or low blast AML: GFM's "pick a winner" trial, with the impact of somatic mutations
Lionel Adès, Nicolas Duployez, Agnes Guerci-Bresler, et al.
Blood
|
April 20, 2022
Prognostic impact of DDX41 germline mutations in intensively treated acute myeloid leukemia patients: an ALFA-FILO study
Nicolas Duployez, Laëtitia Largeaud, Matthieu Duchmann, et al.
American Journal of Hematology
|
December 31, 2013
Azacitidine in untreated acute myeloid leukemia: a report on 149 patients
Sylvain Thépot, Raphael Itzykson, Valerie Seegers, et al.
Nature Communications
|
February 19, 2015
CEACAM1 induces B-cell survival and is essential for protective antiviral antibody production
Vishal Khairnar, Vikas Duhan, Sathish Kumar Maney, et al.
Nature Immunology
|
March 25, 2022
Author Correction: DOCK8 functions as an adaptor that links TLR-MyD88 signaling to B cell activation
Haifa H Jabara, Douglas R McDonald, Erin Janssen, et al.
Nature Immunology
|
May 15, 2012
DOCK8 functions as an adaptor that links TLR-MyD88 signaling to B cell activation
Haifa H Jabara, Douglas R McDonald, Erin Janssen, et al.
Page
of 49